InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: sentiment_stocks post# 16030

Monday, 07/28/2014 12:12:16 AM

Monday, July 28, 2014 12:12:16 AM

Post# of 687079
Very sad story Sentiment. I can't imagine what the couple went through and what he is going through now. To expect 2 years and get only 6 months or 5 functional months.

But I can't follow all the details, nor am I an MD. Not sure if the doctors did much wrong. His main complaint makes sense regarding the patient confidence, but it is not likely to have been a big factor in her longevity.

It would be so difficult, as an Oncologist, to carry that level of responsibility all the time.

I just hope that drug selection is not influenced by marketing and kickbacks, etc.. If so... and it results in people dying or dying sooner, then that is a big deal. Not saying that went on hear, at all. But this reminded me how upset I am about that issue.

You hear it said regularly... ie.. "At least CLDX and NW are not trying to buck SOC with their GBM treatments." That this somehow greatly increases their odds of approval. If that's true, and it is widely accepted to be true, then somebody should hang.

DCVax-L needs Temador. I saw the test results presented by Dr. Lau. It is not about trying to make Merck or the FDA happy. But if keeping SOC increases the odds of a product getting approved, separate and apart from performance, then something is very wrong. And that is the accepted state of the state.

I hope Direct proves out. It seems like a perfect answer to Breast cancer, in part because the guided injections would be so easy in a breast.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News